TelesisBio_Logo_RGB.png
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
May 22, 2023 12:00 ET | Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
TelesisBio_Logo_RGB.png
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
May 18, 2023 10:00 ET | Telesis Bio
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
SynBioBeta.jpg
Synthetic Biology Industry Raises $US10.3 Billion in 2022 with Largest Investments in Synbio Applications, Bio-CAD, and Gene Synthesis and Sequencing with Strong Growth Expected
May 18, 2023 09:05 ET | SynBioBeta
SAN FRANCISCO, May 18, 2023 (GLOBE NEWSWIRE) -- After record-setting investment peaks in FY 2020 and 2021 for synthetic biology, the field raised $10.3 billion in 2022. While this is still a...
MRW.png
Synthetic Biology Market Size 2023 To 2030 | A Comprehensive Analysis Has Been Provided, With A Detailed Competitive Landscape Examination and Projected CAGR Value of 22.0%.
May 15, 2023 06:09 ET | Market Reports World
Pune, May 15, 2023 (GLOBE NEWSWIRE) -- Global Synthetic Biology Market [2023-2030] Research Report Analysis and Outlook Insights | Latest Updated Report | 115 Pages Report | The Synthetic Biology...
Synlogic_Logo_Blue.png
Synlogic Reports First Quarter 2023 Financial Results and Provides Business Update
May 11, 2023 06:50 ET | Synlogic, Inc.
- Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – - Recent milestones include receipt of Rare Pediatric and Orphan Drug Designations from the FDA, and...
Synlogic_Logo_Blue.png
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
May 09, 2023 06:50 ET | Synlogic, Inc.
CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that the U.S. Food and Drug...
MicrosoftTeams-image (5).png
Synthetic Biology Market is Poised to Thrive at CAGR of 21.4 % CAGR During 2023 to 2031 | TMR Report
April 19, 2023 15:30 ET | Transparency Market Research
Wilmington, Delaware, United States, April 20, 2023 (GLOBE NEWSWIRE) -- The global synthetic biology market is anticipated to grow at a 21.4% CAGR from 2023 to 2031. A market valuation of US$ 74.7...
Vantage Market Research.png
Synthetic Biology Market Size & Share to Surpass $85.97 Billion by 2030 | Vantage Market Research
April 17, 2023 06:34 ET | Vantage Market Research
WASHINGTON, April 17, 2023 (GLOBE NEWSWIRE) -- The Global Synthetic Biology Market is valued at USD 12.70 Billion in 2022 and is projected to attain a value of USD 85.97 Billion by 2030 at a CAGR of...
Global Food Biotechnology Market
Global Food Biotechnology Market Report 2023: Rising Need to Improve Yield And Quality of Food Products Drives Demand
April 13, 2023 05:38 ET | Research and Markets
Dublin, April 13, 2023 (GLOBE NEWSWIRE) -- The "Global Food Biotechnology Market (2023-2028) by Type, Application, and Geography, Competitive Analysis, Impact of Economic Slowdown & Impending...
TelesisBio_Logo_RGB.png
Telesis Bio Releases BioXp® Select Kits to Enable DNA Amplification and Scale-up
March 31, 2023 09:00 ET | Telesis Bio
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp®...